Harrow HROW
NASDAQ HROW
$37.56 -0.29 (-0.77%)
As of: Sep 9, 2026 · 2:33 PM EDT

Harrow (HROW) Cash & Current Investments (2010 - 2026)

Harrow (HROW) posted Cash & Current Investments of $83.9 million for Q2 2026, down 11.36% on a QoQ basis from $94.6 million in Q1 2026, and up 58.39% year-over-year from $53.0 million in Q2 2025.

Analysis

Harrow (HROW) Cash & Current Investments (2010 - 2026) Analysis & Trends

Harrow has reported Cash & Current Investments for 17 years, with the latest figure at $83.9 million in Q2 2026.

  • On a quarterly basis, Cash & Current Investments rose 58.39% year-over-year to $83.9 million in Q2 2026; TTM through Jun 2026 was $83.9 million, a 58.39% increase from a year earlier, with the FY2025 full-year figure at $72.9 million, up 54.35% from the prior year.
  • Cash & Current Investments was $83.9 million for Q2 2026 at Harrow, down from $94.6 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $101.9 million in Q4 2022, with the low at $26.9 million in Q1 2023.
  • Average Cash & Current Investments over 5 years is $65.5 million, with a median of $71.8 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: Cash & Current Investments surged 677.83% in 2022, then sank 46.87% in 2023.
  • Over 5 years, Cash & Current Investments stood at $101.9 million in 2022, then slipped by 18.74% to $82.8 million in 2023, then plunged by 42.91% to $47.2 million in 2024, then soared by 54.35% to $72.9 million in 2025, then increased by 15.03% to $83.9 million in 2026.
  • The last three Cash & Current Investments figures came in at $83.9 million (Q2 2026), $94.6 million (Q1 2026), and $72.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Johnson & Johnson 645.95 Bn 625.20 Bn 17.26 Bn 20.76 Bn
2 AbbVie 441.39 Bn 434.82 Bn 12.70 Bn 6.57 Bn
3 Merck 366.72 Bn 359.58 Bn 12.21 Bn 7.14 Bn
4 Novartis Ag 266.68 Bn 258.99 Bn 11.24 Bn 7.69 Bn
5 Pfizer 159.20 Bn 147.50 Bn 10.94 Bn 11.70 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 7.38 Bn
7 Revolution Medicines 44.08 Bn 44.08 Bn - -
8 Incyte 25.50 Bn 20.96 Bn 1.57 Bn 4.54 Bn
9 United Therapeutics 21.54 Bn 18.88 Bn 683.80 Mn 2.66 Bn
10 Harrow 1.40 Bn 1.32 Bn 50.36 Mn 83.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 83.89 Mn
Mar 31, 2026 94.64 Mn
Dec 31, 2025 72.93 Mn
Sep 30, 2025 74.29 Mn
Jun 30, 2025 52.96 Mn
Mar 31, 2025 66.73 Mn
Dec 31, 2024 47.25 Mn
Sep 30, 2024 72.60 Mn
Jun 30, 2024 70.97 Mn
Mar 31, 2024 75.97 Mn
Dec 31, 2023 82.77 Mn
Sep 30, 2023 73.88 Mn
Jun 30, 2023 29.67 Mn
Mar 31, 2023 26.88 Mn
Dec 31, 2022 101.86 Mn
Sep 30, 2022 49.12 Mn
Jun 30, 2022 51.63 Mn
Mar 31, 2022 50.59 Mn
Dec 31, 2021 50.67 Mn
Sep 30, 2021 67.85 Mn